A subunit vaccine is a vaccine that contains purified parts of the pathogen that are antigenic, or necessary to elicit a protective immune response. Subunit... 67 KB (6,747 words) - 00:37, 12 April 2024 |
Zealand Sinopharm CNBG COVID-19 vaccine (NVSI) is a recombinant protein subunit vaccine developed by the National Vaccine & Serum Institute (NVSI, 中生研究院)... 318 KB (19,351 words) - 20:00, 21 April 2024 |
The Novavax COVID-19 vaccine, sold under the brand names Nuvaxovid and Covovax, among others, is a subunit COVID-19 vaccine developed by Novavax and the... 65 KB (4,734 words) - 04:34, 31 March 2024 |
infected. There are other vaccine candidates in development including live attenuated, inactivated, DNA and subunit vaccines. In December 2018, Dengvaxia... 39 KB (3,733 words) - 03:19, 31 March 2024 |
that a vaccine would be available within ten years. Candidates included particle-based vaccines, attenuated vaccines, mRNA vaccines, protein subunit vaccines... 36 KB (3,089 words) - 04:30, 2 April 2024 |